GC Therapeutics, Inc. (GCTx), a biotechnology company created to scale and unlock the next generation of cell therapy-based medicines through its TFome™ cellular programming platform, today announced ...

Using a blend of computer modeling, structural and cell-based studies, scientists at The Wertheim UF Scripps Institute have ...

For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important ...

As the “Predictability Era” Ends, Global Summits, Corporate Conferences, and Boards Turn to Spitz’s “Operating System” ...

Understand the role of reproductive biotech in overcoming biological limits in fertility treatments and enhancing success ...

Researchers at the University of British Columbia (UBC) have made a significant discovery regarding the cultivation of ...

AI-Focused Genomics Company Advancing De-Aging Science Collaborates with Leading iPS Cell Manufacturing and Research ...

Richard Smith's “WhiteGrass” Delivers a Riveting Blend of Cli-Fi, AI Ethics, and Family Drama NY, UNITED STATES, ...

For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important type of human immune cell-known as helper T cells-from stem cells in a ...

Encephalitis is an inflammation of the brain that can be caused by infections or autoimmune reactions. Even when patients survive the acute phase, many are left with long-lasting neurological problems ...

For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important type of human immune ...

SonoTheratm, a biotechnology company dedicated to treating the root cause of human diseases by developing the next generation of genetic medicines, today announced it will officially launch a $125M ...